Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Phase I Study of Col-3 Administered on a Continuous Oral Schedule in Patients with Recurrent High Grade Glioma: Results of the NABTT 9809 Clinical Trial
003
Authors/Disclosures
Sankar Bandyopadhyay, MD, FÂ鶹´«Ã½Ó³»­ (Penn State Hershey Medical Center) Dr. Bandyopadhyay has nothing to disclose.
No disclosure on file